2018
DOI: 10.1007/s40675-018-0112-9
|View full text |Cite
|
Sign up to set email alerts
|

Sleep and Dementia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 66 publications
1
8
0
Order By: Relevance
“…Recent attempts to establish sleep as a novel biomarker and treatment target for Alzheimer's disease have instantly evoked a massive rise in research on sleep and aging (Ju et al, ; Mander et al, ; Noble & Spires‐Jones, ; Vaou et al, ). Methodological considerations, though, call for a clarification of what we want to measure and how we can best assess the respective phenomena.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Recent attempts to establish sleep as a novel biomarker and treatment target for Alzheimer's disease have instantly evoked a massive rise in research on sleep and aging (Ju et al, ; Mander et al, ; Noble & Spires‐Jones, ; Vaou et al, ). Methodological considerations, though, call for a clarification of what we want to measure and how we can best assess the respective phenomena.…”
Section: Resultsmentioning
confidence: 99%
“…In search of novel biomarkers and treatment targets for age‐related pathologies, sleep has recently attracted much attention. Disrupted sleep represents one of the earliest symptoms of Alzheimer's disease (Lim, Kowgier, Yu, Buchman, & Bennett, ; Lucey et al, ), but might also potentiate, accelerate, or even cause cognitive pathology in old age (Shokri‐Kojori et al, ; Vaou, Lin, Branson, & Auerbach, ). Because of the assumed bidirectional relationship between sleep and Alzheimer's pathology (Ju, Lucey, & Holtzman, ; Mander, Winer, Jagust, & Walker, ; Noble & Spires‐Jones, ; Vaou et al, ; Winer et al, ), studying the interrelations between sleep and neurocognitive aging has become increasingly popular.…”
Section: Introductionmentioning
confidence: 99%
“…Recent attempts to establish sleep as a novel biomarker and treatment target for Alzheimer's disease have instantly evoked a massive rise in research on sleep and aging (Ju et al, 2014;Mander et al, 2016;Noble and Spires-Jones, 2019;Vaou et al, 2018). Methodological considerations, though, call for a clarification of what we want to measure and how we can best assess the respective phenomena.…”
Section: Resultsmentioning
confidence: 99%
“…In search of novel biomarkers and treatment targets for age-related pathologies, sleep has recently attracted much attention. Disrupted sleep represents one of the earliest symptoms of Alzheimer's disease (Lim et al, 2013;Lucey et al, 2019), but might also potentiate, accelerate, or even cause cognitive pathology in old age (Shokri-Kojori et al, 2018;Vaou et al, 2018). Because of the assumed bidirectional relationship between sleep and Alzheimer's pathology (Ju et al, 2014;Mander et al, 2016;Noble and Spires-Jones, 2019;Vaou et al, 2018;Winer et al, 2019), studying the interrelations between sleep and neurocognitive aging has become increasingly popular.…”
Section: Introductionmentioning
confidence: 99%
“…For example, in the elderly with normal cognition, amyloid deposits measured by positron emission tomography (PET) and Aβ42 levels in cerebrospinal fluid increased with self-reported decreasing sleep duration, 41 excessive daytime sleep, 42 longer sleep latency, 43 , 44 and poorer sleep quality. 45 , 46 On the other hand, sleep deprivation increases the production of amyloid-β and reduces its clearance, 47 which leads to a higher risk of cognitive impairment. 48–51 …”
Section: Introductionmentioning
confidence: 99%